[go: up one dir, main page]
More Web Proxy on the site http://driver.im/

MA25432A1 - Formulation veterinaire pour l'administration d'un medicament insoluble dans l'eau a un animal cible par un systeme de distribution de l'eau. - Google Patents

Formulation veterinaire pour l'administration d'un medicament insoluble dans l'eau a un animal cible par un systeme de distribution de l'eau.

Info

Publication number
MA25432A1
MA25432A1 MA26537A MA26537A MA25432A1 MA 25432 A1 MA25432 A1 MA 25432A1 MA 26537 A MA26537 A MA 26537A MA 26537 A MA26537 A MA 26537A MA 25432 A1 MA25432 A1 MA 25432A1
Authority
MA
Morocco
Prior art keywords
water
administration
distribution system
target animal
veterinary formulation
Prior art date
Application number
MA26537A
Other languages
English (en)
Inventor
Mario Van Wandelen
Jan Matthijs Jetten
Peter Frank Ekhart
Original Assignee
Janssen Pharmaceutica Nv
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Janssen Pharmaceutica Nv filed Critical Janssen Pharmaceutica Nv
Publication of MA25432A1 publication Critical patent/MA25432A1/fr

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A61K9/107—Emulsions ; Emulsion preconcentrates; Micelles
    • A61K9/1075—Microemulsions or submicron emulsions; Preconcentrates or solids thereof; Micelles, e.g. made of phospholipids or block copolymers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/415—1,2-Diazoles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/36—Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/44—Oils, fats or waxes according to two or more groups of A61K47/02-A61K47/42; Natural or modified natural oils, fats or waxes, e.g. castor oil, polyethoxylated castor oil, montan wax, lignite, shellac, rosin, beeswax or lanolin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00—Antiparasitic agents
    • A61P33/10—Anthelmintics

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Epidemiology (AREA)
  • Dispersion Chemistry (AREA)
  • Biophysics (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Inorganic Chemistry (AREA)
  • Molecular Biology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
  • Fodder In General (AREA)
  • Colloid Chemistry (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
MA26537A 1999-09-03 2002-03-01 Formulation veterinaire pour l'administration d'un medicament insoluble dans l'eau a un animal cible par un systeme de distribution de l'eau. MA25432A1 (fr)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
EP99202876 1999-09-03

Publications (1)

Publication Number Publication Date
MA25432A1 true MA25432A1 (fr) 2002-04-01

Family

ID=8240608

Family Applications (1)

Application Number Title Priority Date Filing Date
MA26537A MA25432A1 (fr) 1999-09-03 2002-03-01 Formulation veterinaire pour l'administration d'un medicament insoluble dans l'eau a un animal cible par un systeme de distribution de l'eau.

Country Status (35)

Country Link
US (1) US9040571B2 (fr)
EP (1) EP1214052B1 (fr)
JP (1) JP4754139B2 (fr)
KR (1) KR100702540B1 (fr)
CN (1) CN1165289C (fr)
AR (1) AR025470A1 (fr)
AT (1) ATE273000T1 (fr)
AU (1) AU775216B2 (fr)
BG (1) BG65673B1 (fr)
BR (1) BR0013754A (fr)
CA (1) CA2383164C (fr)
CZ (1) CZ301938B6 (fr)
DE (1) DE60012947T2 (fr)
EA (1) EA004785B1 (fr)
EE (1) EE05052B1 (fr)
ES (1) ES2226914T3 (fr)
HK (1) HK1049628B (fr)
HR (1) HRP20020173B1 (fr)
HU (1) HU229311B1 (fr)
IL (2) IL148438A0 (fr)
MA (1) MA25432A1 (fr)
ME (1) ME00132B (fr)
MX (1) MXPA02002360A (fr)
MY (1) MY128072A (fr)
NZ (1) NZ517024A (fr)
PL (1) PL201484B1 (fr)
PT (1) PT1214052E (fr)
RS (1) RS50341B (fr)
SI (1) SI1214052T1 (fr)
SK (1) SK285825B6 (fr)
TR (1) TR200200532T2 (fr)
TW (1) TWI234468B (fr)
UA (1) UA72933C2 (fr)
WO (1) WO2001017504A1 (fr)
ZA (1) ZA200201708B (fr)

Families Citing this family (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1379242B1 (fr) * 2001-03-26 2012-08-15 Newsouth Innovations Pty Limited Methode de traitement de cancers et compositions appropriees
JP5227795B2 (ja) 2005-07-28 2013-07-03 インターベツト・インターナシヨナル・ベー・ベー 抗寄生虫活性を有する新規ベンゾイミダゾール（チオ）カルバメートおよびその合成
PL2037914T3 (pl) * 2006-06-14 2014-04-30 Intervet Int Bv Zawiesina zawierająca karbaminian benzoimidazolu i polisorbat
TWI400243B (zh) 2009-07-20 2013-07-01 Intervet Int Bv 製造西喹諾（ｃｅｆｑｕｉｎｏｍｅ）粒子的方法
EP2409683A1 (fr) 2010-07-06 2012-01-25 KRKA, D.D., Novo Mesto Formulations aqueuses stables comprenant des ingrédients actifs faiblement solubles dans l'eau
RU2522267C2 (ru) * 2012-08-28 2014-07-10 Федеральное государственное бюджетное образовательное учреждение высшего профессионального образования Курская государственная сельскохозяйственная академия имени профессора И.И. Иванова Министерства сельского хозяйства Российской Федерации Способ инкапсуляции фенбендазола
RU2522229C1 (ru) * 2013-03-26 2014-07-10 Федеральное государственное бюджетное образовательное учреждение высшего профессионального образования "Юго-Западный государственный университет" (ЮЗ ГУ) Способ инкапсуляции фенбендазола
RU2545742C2 (ru) * 2013-07-23 2015-04-10 Александр Александрович Кролевец Способ инкапсуляции лактобифадола
RU2555782C1 (ru) * 2014-03-03 2015-07-10 Александр Александрович Кролевец Способ получения нанокапсул сульфата глюкозамина в конжаковой камеди в гексане
RU2558084C1 (ru) * 2014-03-18 2015-07-27 Александр Александрович Кролевец Способ получения нанокапсул аспирина в каррагинане
RU2555055C1 (ru) * 2014-03-18 2015-07-10 Александр Александрович Кролевец Способ получения нанокапсул сульфата глюкозамина в ксантановой камеди
RU2557941C1 (ru) * 2014-03-20 2015-07-27 Александр Александрович Кролевец Способ получения нанокапсул аспирина в альгинате натрия
RU2554759C1 (ru) * 2014-04-07 2015-06-27 Александр Александрович Кролевец Способ получения нанокапсул лозартана калия
CN109152842B (zh) * 2016-04-29 2022-10-28 罗赛洛公司 用于活性药物成分的基于蛋白质的赋形剂
CN110151692A (zh) * 2019-06-21 2019-08-23 石家庄九鼎动物药业有限公司 一种兽用抗寄生虫药物阿苯达唑混悬液制备方法
CN110693830B (zh) * 2019-10-10 2021-09-17 华中农业大学 一种兽用奥芬达唑纳米混悬液及其制备方法

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2336931A1 (fr) * 1975-12-30 1977-07-29 Dick Pierre Compositions anthelminthiques a base de benzimidazoles
US5538989A (en) * 1993-11-10 1996-07-23 Hoechst-Roussel Agri-Vet Company Fenbendazole formulations
NZ260018A (en) * 1994-03-03 1995-10-26 Bomac Lab Ltd Benzimidazole compositions and anthelmintic compositions

Also Published As

Publication number Publication date
ZA200201708B (en) 2003-08-27
HRP20020173A2 (en) 2004-04-30
MY128072A (en) 2007-01-31
RS50341B (sr) 2009-11-10
JP2003508482A (ja) 2003-03-04
MXPA02002360A (es) 2002-07-30
HK1049628A1 (en) 2003-05-23
EE200200094A (et) 2003-04-15
PT1214052E (pt) 2004-12-31
EE05052B1 (et) 2008-08-15
CZ301938B6 (cs) 2010-08-04
IL148438A (en) 2006-12-10
CN1165289C (zh) 2004-09-08
HRP20020173B1 (en) 2005-02-28
SK2642002A3 (en) 2002-12-03
SK285825B6 (sk) 2007-09-06
DE60012947D1 (de) 2004-09-16
AU775216B2 (en) 2004-07-22
ME00132B (me) 2010-10-10
ES2226914T3 (es) 2005-04-01
TR200200532T2 (tr) 2002-07-22
PL201484B1 (pl) 2009-04-30
WO2001017504A1 (fr) 2001-03-15
BR0013754A (pt) 2002-05-21
EP1214052B1 (fr) 2004-08-11
UA72933C2 (uk) 2005-05-16
TWI234468B (en) 2005-06-21
AU7322900A (en) 2001-04-10
BG65673B1 (bg) 2009-06-30
CA2383164C (fr) 2008-07-08
JP4754139B2 (ja) 2011-08-24
PL353481A1 (en) 2003-11-17
US20090062362A1 (en) 2009-03-05
HU229311B1 (en) 2013-10-28
IL148438A0 (en) 2002-09-12
ATE273000T1 (de) 2004-08-15
BG106448A (en) 2002-09-30
EA200200325A1 (ru) 2002-08-29
YU14302A (sh) 2004-11-25
KR20020063844A (ko) 2002-08-05
EP1214052A1 (fr) 2002-06-19
MEP9108A (en) 2010-06-10
CZ2002630A3 (cs) 2002-09-11
AR025470A1 (es) 2002-11-27
CA2383164A1 (fr) 2001-03-15
US9040571B2 (en) 2015-05-26
HUP0202686A2 (hu) 2004-05-28
DE60012947T2 (de) 2005-08-25
SI1214052T1 (en) 2005-02-28
EA004785B1 (ru) 2004-08-26
HK1049628B (zh) 2005-05-13
HUP0202686A3 (en) 2004-06-28
KR100702540B1 (ko) 2007-04-04
NZ517024A (en) 2003-05-30
CN1372462A (zh) 2002-10-02

Similar Documents

Publication Publication Date Title
MA25432A1 (fr) Formulation veterinaire pour l'administration d'un medicament insoluble dans l'eau a un animal cible par un systeme de distribution de l'eau.
MA26456A1 (fr) Formulations pharmaceutiques pour la distribution prolongee de medicament.
FR2792842B1 (fr) Systeme de delivrance de bolus de medicament
DE60013445D1 (de) Pharmazeutische dosierungsformen zur kontrollierter pulsierender abgabe
DE69906518D1 (de) Arzneistoff-abgabesystem enthaltend eine festgepackte, feste arzneistoffbasis
CA2246235A1 (fr) Administration de nicotine par le colon en vue de traiter les affections intestinales inflammatoires
FR2797772B1 (fr) Moyen pour activer un dispositif d'administration par ionophorese
FR2698787B1 (fr) Patches médicinaux pour administration par voie percutanée.
DE69721481D1 (de) Wirkstoffformulierungen mit verzögerter freisetzung
CA2301017A1 (fr) Utilisation de gallate de propyle pour augmenter la biodisponibilite de produits pharmaceutiques administres par voie orale
ATE226450T1 (de) Gepufferte orthoesterpolymere enthaltende arzneimittel
CA2383212A1 (fr) Dosage oral a liberation regulee destine a l'administration orale
PT95168A (pt) Forma de dosagem para libertar farmacos soluveis ou insoluveis
SE9603480D0 (sv) Beredningsform för svårlösliga läkemedel
ATE285779T1 (de) Ciclesonidhaltige arzneizusammensetzung zur verabreichung auf die schleimhäute
FR2796921B1 (fr) Dispositif de distribution de produit fluide avec systeme d'obturation
FR2796287B1 (fr) Dispositif d'administration de medicament
ATE315382T1 (de) Pharmazeutische zusammensetzungen zur oralen verabreichung, die einen magensaftresistenten überzug auf der basis von acrylatpolymeren enthalten
GB9924636D0 (en) Laxative preparation
FR2799977B1 (fr) Systeme d'injection de produits pharmaceutiques pourvu de moyens de neutralisation de l'aiguille apres utilisation
CO4910116A1 (es) Formulacion de liberacion controlada para farmacos basicos escasamente solubles
GT199700078A (es) Formulacion de liberacion controlada para farmacos basicos escasamente solubles
FR2702960B1 (fr) Leurre pour l'administration orale de médicaments vétérinaires.
DK1214052T3 (da) Veterinærformulering til indgivelse af et vanduoplöseligt lægemiddel til et måldyr via et vandfordelingssystem
MC200018A1 (fr) Procede pour la preparation d'un medicament a base de Diclofenac Sodic + vitamine C en solution liquide sous forme de comprime effervescent